Showing results (231-240 of 283) with videos related to
Sort By:
Pageof 29
Drug Safety|February 25, 2009
Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) projectJune M McKoy, Charles L Bennett, Marc H Scheetz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports projectLisa A Ladewski, Steven M Belknap, Jonathan R Nebeker, et al.Stroke|January 7, 2004
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug AdministrationAnaadriana Zakarija, Nicholas Bandarenko, Dilip K Pandey, et al.International Journal of Cancer|February 11, 2020
End of an era for erythropoiesis-stimulating agents in oncologyMartin W Schoen, Shamia Hoque, Bartlett J Witherspoon, et al.Blood|October 24, 2007
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline updateJ Douglas Rizzo, Mark R Somerfield, Karen L Hagerty, et al.Blood|January 9, 2017
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphomaKilannin Krysiak, Felicia Gomez, Brian S White, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline updateJ Douglas Rizzo, Mark R Somerfield, Karen L Hagerty, et al.British Journal of Haematology|December 3, 2015
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trialRanjana H Advani, Stephen M Ansell, Mary J Lechowicz, et al.Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.The Review of Scientific Instruments|March 2, 2022
SiAl composite feedhorn arrays for astrophysical applications: Cryogenic material propertiesAamir M Ali, Thomas Essinger-Hileman, Tobias Marriage, et al.Pageof 29